Literature DB >> 19285964

Efficient inhibition of fibroblast proliferation and collagen expression by ERK2 siRNAs.

Fengfeng Li1, Cunyi Fan, Tao Cheng, Chaoyin Jiang, Bingfang Zeng.   

Abstract

Transforming growth factor-beta1 and fibroblast growth factor-2 play very important roles in fibroblast proliferation and collagen expression. These processes lead to the formation of joint adhesions through the SMAD and MAPK pathways, in which ERK2 is supposed to be crucial. Based on these assumptions, lentivirus (LV)-mediated small interfering RNAs (siRNAs) targeting ERK2 were used to suppress the proliferation and collagen expression of rat joint adhesion tissue fibroblasts (RJATFs). Among four siRNAs examined, siRNA1 caused an 84% reduction in ERK2 expression (p<0.01) and was selected as the most efficient siRNA for use in this study. In subsequent experiments, significant downregulation of types I and III collagen were observed by quantitative RT-PCR and Western blot analyses. MTT assays and flow cytometry revealed marked inhibition of RJATF proliferation, but no apoptosis. In conclusion, LV-mediated ERK2 siRNAs may represent novel therapies or drug targets for preventing joint adhesion formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285964     DOI: 10.1016/j.bbrc.2009.02.165

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Smad linker region phosphorylation in the regulation of extracellular matrix synthesis.

Authors:  Micah L Burch; Wenhua Zheng; Peter J Little
Journal:  Cell Mol Life Sci       Date:  2010-09-04       Impact factor: 9.261

2.  shRNA targeting SFRP2 promotes the apoptosis of hypertrophic scar fibroblast.

Authors:  Zhicheng Sun; Shirong Li; Chuan Cao; Jun Wu; Bing Ma; Vu Tran
Journal:  Mol Cell Biochem       Date:  2011-02-02       Impact factor: 3.396

3.  Investigating the role of P311 in the hypertrophic scar.

Authors:  Jianglin Tan; Xu Peng; Gaoxing Luo; Bing Ma; Chuan Cao; Weifeng He; Shunzong Yuan; Shirong Li; John A Wilkins; Jun Wu
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

4.  Hydrolyzed eggshell membrane immobilized on phosphorylcholine polymer supplies extracellular matrix environment for human dermal fibroblasts.

Authors:  Eri Ohto-Fujita; Tomohiro Konno; Miho Shimizu; Kazuhiko Ishihara; Toshihiro Sugitate; Jun Miyake; Kotaro Yoshimura; Kaori Taniwaki; Takashi Sakurai; Yukio Hasebe; Yoriko Atomi
Journal:  Cell Tissue Res       Date:  2011-05-20       Impact factor: 5.249

5.  ERK2 and JNK1 contribute to TNF-α-induced IL-8 expression in synovial fibroblasts.

Authors:  Shinichi Namba; Rei Nakano; Taku Kitanaka; Nanako Kitanaka; Tomohiro Nakayama; Hiroshi Sugiya
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

6.  RelA/p65 inhibition prevents tendon adhesion by modulating inflammation, cell proliferation, and apoptosis.

Authors:  Shuai Chen; Shichao Jiang; Wei Zheng; Bing Tu; Shen Liu; Hongjiang Ruan; Cunyi Fan
Journal:  Cell Death Dis       Date:  2017-03-30       Impact factor: 8.469

7.  ERK1/ATF-2 signaling axis contributes to interleukin-1β-induced MMP-3 expression in dermal fibroblasts.

Authors:  Nanako Kitanaka; Rei Nakano; Manabu Sakai; Taku Kitanaka; Shinichi Namba; Tadayoshi Konno; Tomohiro Nakayama; Hiroshi Sugiya
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

8.  Prevention of Tendon Adhesions by ERK2 Small Interfering RNAs.

Authors:  Hongjiang Ruan; Shen Liu; Fengfeng Li; Xujun Li; Cunyi Fan
Journal:  Int J Mol Sci       Date:  2013-02-21       Impact factor: 5.923

9.  Lentivirus-mediated ERK2 siRNA reduces joint capsule fibrosis in a rat model of post-traumatic joint contracture.

Authors:  Fengfeng Li; Shen Liu; Cunyi Fan
Journal:  Int J Mol Sci       Date:  2013-10-17       Impact factor: 5.923

Review 10.  Redundancy in the World of MAP Kinases: All for One.

Authors:  Marc K Saba-El-Leil; Christophe Frémin; Sylvain Meloche
Journal:  Front Cell Dev Biol       Date:  2016-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.